APA (7th ed.) Citation

Laux, G., Berger, S., Szecsenyi, J., Kaufmann-Kolle, P., & Leutgeb, R. (2016). Prescribing differences in family practice for diabetic patients in Germany according to statutory or private health insurance: The case of DPP-4-inhibitors and GLP-1-agonists. BioMed Central; Springer. https://doi.org/10.1186/s12875-016-0543-7

Chicago Style (17th ed.) Citation

Laux, Gunter, Sarah Berger, Joachim Szecsenyi, Petra Kaufmann-Kolle, and Rüdiger Leutgeb. Prescribing Differences in Family Practice for Diabetic Patients in Germany According to Statutory or Private Health Insurance: The Case of DPP-4-inhibitors and GLP-1-agonists. London; Berlin; Heidelberg: BioMed Central; Springer, 2016. https://doi.org/10.1186/s12875-016-0543-7.

MLA (9th ed.) Citation

Laux, Gunter, et al. Prescribing Differences in Family Practice for Diabetic Patients in Germany According to Statutory or Private Health Insurance: The Case of DPP-4-inhibitors and GLP-1-agonists. BioMed Central; Springer, 2016. https://doi.org/10.1186/s12875-016-0543-7.